top of page


Abcuro is a biopharmaceutical company developing a new generation of immunomodulatory therapeutics for treating both autoimmunity and cancer. Abcuro recently began clinical studies, as well as hired Dr. Niti Goel as the new Chief Medical Officer.
bottom of page